Medical Tourism Market Size, Share, and Trends 2024 to 2034

The global medical tourism market size calculated at USD 43.51 billion in 2025 and is expected to reach around USD 252.94 billion by 2034, expanding at a CAGR of 21.60% from 2025 to 2034. The North America medical tourism market size reached USD 9.30 billion in 2024 and is expanding at a CAGR of 21.64% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : January 2025
  • Report Code : 1360
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Medical Tourism Market 

5.1. COVID-19 Landscape: Medical Tourism Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Medical Tourism Market, By Treatment Type

8.1. Medical Tourism Market, by Treatment Type,

8.1.1. Dental Treatment

8.1.1.1. Market Revenue and Forecast

8.1.2. Cardiovascular Treatment

8.1.2.1. Market Revenue and Forecast

8.1.3. Cancer Treatment

8.1.3.1. Market Revenue and Forecast

8.1.4. Cosmetic Treatment

8.1.4.1. Market Revenue and Forecast

8.1.5. Orthopedic Treatment

8.1.5.1. Market Revenue and Forecast

8.1.6. Fertility Treatment

8.1.6.1. Market Revenue and Forecast

8.1.7. Neurological Treatment

8.1.7.1. Market Revenue and Forecast

8.1.8. Other

8.1.8.1. Market Revenue and Forecast

Chapter 9. Global Medical Tourism Market, By Service Providers

9.1. Medical Tourism Market, by Service Providers,

9.1.1. Public

9.1.1.1. Market Revenue and Forecast

9.1.2. Private

9.1.2.1. Market Revenue and Forecast

Chapter 10. Global Medical Tourism Market, By Type 

10.1. Medical Tourism Market, by Type,

10.1.1. Domestic

10.1.1.1. Market Revenue and Forecast

10.1.2. International

10.1.2.1. Market Revenue and Forecast

Chapter 11. Global Medical Tourism Market, By Healthcare Service 

11.1. Medical Tourism Market, by Healthcare Service,

11.1.1. Medical Treatment

11.1.1.1. Market Revenue and Forecast

11.1.2. Wellness

11.1.2.1. Market Revenue and Forecast

11.1.3. Alternative Treatment

11.1.3.1. Market Revenue and Forecast

Chapter 12. Global Medical Tourism Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Treatment Type

12.1.2. Market Revenue and Forecast, by Service Providers

12.1.3. Market Revenue and Forecast, by Type

12.1.4. Market Revenue and Forecast, by Healthcare Service

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Treatment Type

12.1.5.2. Market Revenue and Forecast, by Service Providers

12.1.5.3. Market Revenue and Forecast, by Type

12.1.5.4. Market Revenue and Forecast, by Healthcare Service

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Treatment Type

12.1.6.2. Market Revenue and Forecast, by Service Providers

12.1.6.3. Market Revenue and Forecast, by Type

12.1.6.4. Market Revenue and Forecast, by Healthcare Service

12.2. Europe

12.2.1. Market Revenue and Forecast, by Treatment Type

12.2.2. Market Revenue and Forecast, by Service Providers

12.2.3. Market Revenue and Forecast, by Type

12.2.4. Market Revenue and Forecast, by Healthcare Service

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Treatment Type

12.2.5.2. Market Revenue and Forecast, by Service Providers

12.2.5.3. Market Revenue and Forecast, by Type

12.2.5.4. Market Revenue and Forecast, by Healthcare Service

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Treatment Type

12.2.6.2. Market Revenue and Forecast, by Service Providers

12.2.6.3. Market Revenue and Forecast, by Type

12.2.6.4. Market Revenue and Forecast, by Healthcare Service

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Treatment Type

12.2.7.2. Market Revenue and Forecast, by Service Providers

12.2.7.3. Market Revenue and Forecast, by Type

12.2.7.4. Market Revenue and Forecast, by Healthcare Service

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Treatment Type

12.2.8.2. Market Revenue and Forecast, by Service Providers

12.2.8.3. Market Revenue and Forecast, by Type

12.2.8.4. Market Revenue and Forecast, by Healthcare Service

12.3. APAC

12.3.1. Market Revenue and Forecast, by Treatment Type

12.3.2. Market Revenue and Forecast, by Service Providers

12.3.3. Market Revenue and Forecast, by Type

12.3.4. Market Revenue and Forecast, by Healthcare Service

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Treatment Type

12.3.5.2. Market Revenue and Forecast, by Service Providers

12.3.5.3. Market Revenue and Forecast, by Type

12.3.5.4. Market Revenue and Forecast, by Healthcare Service

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Treatment Type

12.3.6.2. Market Revenue and Forecast, by Service Providers

12.3.6.3. Market Revenue and Forecast, by Type

12.3.6.4. Market Revenue and Forecast, by Healthcare Service

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Treatment Type

12.3.7.2. Market Revenue and Forecast, by Service Providers

12.3.7.3. Market Revenue and Forecast, by Type

12.3.7.4. Market Revenue and Forecast, by Healthcare Service

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Treatment Type

12.3.8.2. Market Revenue and Forecast, by Service Providers

12.3.8.3. Market Revenue and Forecast, by Type

12.3.8.4. Market Revenue and Forecast, by Healthcare Service

12.4. MEA

12.4.1. Market Revenue and Forecast, by Treatment Type

12.4.2. Market Revenue and Forecast, by Service Providers

12.4.3. Market Revenue and Forecast, by Type

12.4.4. Market Revenue and Forecast, by Healthcare Service

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Treatment Type

12.4.5.2. Market Revenue and Forecast, by Service Providers

12.4.5.3. Market Revenue and Forecast, by Type

12.4.5.4. Market Revenue and Forecast, by Healthcare Service

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Treatment Type

12.4.6.2. Market Revenue and Forecast, by Service Providers

12.4.6.3. Market Revenue and Forecast, by Type

12.4.6.4. Market Revenue and Forecast, by Healthcare Service

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Treatment Type

12.4.7.2. Market Revenue and Forecast, by Service Providers

12.4.7.3. Market Revenue and Forecast, by Type

12.4.7.4. Market Revenue and Forecast, by Healthcare Service

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Treatment Type

12.4.8.2. Market Revenue and Forecast, by Service Providers

12.4.8.3. Market Revenue and Forecast, by Type

12.4.8.4. Market Revenue and Forecast, by Healthcare Service

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Treatment Type

12.5.2. Market Revenue and Forecast, by Service Providers

12.5.3. Market Revenue and Forecast, by Type

12.5.4. Market Revenue and Forecast, by Healthcare Service

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Treatment Type

12.5.5.2. Market Revenue and Forecast, by Service Providers

12.5.5.3. Market Revenue and Forecast, by Type

12.5.5.4. Market Revenue and Forecast, by Healthcare Service

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Treatment Type

12.5.6.2. Market Revenue and Forecast, by Service Providers

12.5.6.3. Market Revenue and Forecast, by Type

12.5.6.4. Market Revenue and Forecast, by Healthcare Service

Chapter 13. Company Profiles

13.1. Aditya Birla Memorial Hospital

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Apollo Hospitals Enterprise

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Asian Heart Institute

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Barbados Fertility Center

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Fortis Healthcare Limited

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. KPJ Healthcare Berhad

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. NTT Medical Center Tokyo

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Prince Court Medical Centre

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Samitivej PCL

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Seoul National University Hospital

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global medical tourism market size was reached at USD 35.78 billion in 2024 and is projected to hit over USD 252.94 billion by 2034.

The global medical tourism market is primarily driven by the increased demand for the cheap treatment for various chronic diseases available in the developing countries.

The global medical tourism market is growing at a CAGR of 21.60% during the forecast period 2025 to 2034.

The major players operating in the medical tourism market are Aditya Birla Memorial Hospital, Apollo Hospitals Enterprise, Asian Heart Institute, Barbados Fertility Center, Fortis Healthcare Limited, KPJ Healthcare Berhad, NTT Medical Center Tokyo, Prince Court Medical Centre, Samitivej PCL, Seoul National University Hospital, Wooridul Spine Hospital.

The North America is also estimated to be the fastest-growing region during the forthcoming years.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client